Dr Graham Jackson, Consultant Haematologist and Senior Lecturer, Royal Victoria Hospital, Newcastle upon Tyne, explains what happens when myeloma returns. According to Myeloma UK, around 10 people are diagnosed with multiple myeloma in the UK every day. Myeloma is the second most common form of bone marrow cancer in the UK and is currently incurable, but treatable.
Myeloma UK Chief Executive, Eric Low, speaks about the u-turn by NICE on myeloma drug Velcade -- a move which looks set to approve use of the drug on the NHS after being turned down in 2006
In this interview on BBC Breakfast News on 4 June, myeloma patient, Jacky Pickles, one of the Velcade 3 discusses the potential impact of the recent NICE announcement on Velcade.
